| Gene symbol | SLAMF7 | Synonyms | 19A, CD319, CRACC, CS1 | Type of gene | protein-coding |
| Chromosome | 1 | Map location | 1q23.3 | dbXrefs | |
| Description | SLAM family member 7 | ||||
| GTO ID | GTC2413 |
| Trial ID | NCT04499339 |
| Disease | Multiple Myeloma |
| Altered gene | SLAMF7 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | SLAMF7 CAR-T cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Active, Not Recruiting |
| Title | A Phase I/IIa Clinical Trial to Assess Feasibility, Safety and Antitumor Activity of Autologous SLAMF7 CAR-T Cells in Multiple Myeloma |
| Year | 2020 |
| Country | Germany |
| Company sponsor | Wuerzburg University Hospital |
| Other ID(s) | CARAMBA-1|2019-001264-30 |
| Cohort 1 | |||||||||
|
|||||||||